MMS Set to Expand Disclosure Services with Registry Reporting Software TrialAssure
Summary
Our strong industry experience and scientific approach to drug development makes us a valuable partner in creating compelling submissions that meet rigorous regulatory standards.For more information visit: http://www.mmsholdings.com Canton, MI, March 02, 2013 --( PR.com )-- MMS Holdings Inc. today announced that it has successfully executed disclosure management services for several clients and is poised to make strides in this area with its proprietary software, TrialAssure™.TrialAssure™ is a workflow management system that supports the reporting of clinical, financial and company information.In addition to the software, MMS has the technical leadership in the disclosure arena.Joe Archer leads the disclosure teams at MMS and brings with him a depth of technical experience and regulatory feedback on the process.Our strong industry experience and scientific approach to drug development makes us a valuable partner in creating compelling submissions that meet rigorous regulatory standards.